|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02500 VENUS MEDTECH-B
Nominal 
2.700 +0.100 (+3.846%) | 2024/12 - Final RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | |
| Net Cash from / (used in) Operating Activities | 23,739 | (610,019) | (729,459) | (456,917) | (237,005) |
| Net Cash from / (used in) Investing Activities | (19,898) | (346,859) | (1,072,266) | (653,038) | (297,943) |
| Net Cash from / (used in) Financing Activities | (487,339) | (173,986) | 635,137 | 1,391,401 | 927,751 |
| Increase / (Decrease) in Cash & Cash Equivalents | (483,498) | (1,130,864) | (1,166,588) | 281,446 | 392,803 |
| Cash & Cash Equivalents at beginning of period | 774,396 | 1,879,431 | 2,955,212 | 2,708,170 | 2,413,254 |
| Effect of Foreign Exchange Rate Changes | 7,138 | 25,829 | 90,807 | (34,404) | (97,887) |
| Others | 0 | 0 | 0 | 0 | 0 |
| Cash & Cash Equivalents at end of period | 298,036 | 774,396 | 1,879,431 | 2,955,212 | 2,708,170 |
| Remarks: | Real time quote last updated: 23/07/2025 18:00 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB -714,307 |
| %Change | 1.500% |
| EPS / (LPS) | RMB -1.630 |
| NBV Per Share (¥) | RMB 5.014 |